300+ investors in your industry, stage, and region Get
Any industry
Google
Biotech
Proptech
Climate
Artificial Intelligence
Impact
EdTech
Sustainability
Clean Energy
Digital Media
Local
Enterprise Software
Travel
Platforms
Recruiting
Social
Wine and Spirits
Mobile Apps
InsurTech
Retail
Finance
Theatre
Oil and Gas
Non Profit
Celebrity
Social Impact
Cryptocurrency
Film
Crowdfunding
Venture Capital
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Payments
Renewable Energy
Organic Food
Email
Financial Services
Manufacturing
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Community
Hardware
Gaming
SaaS
Facebook
Media (Entertainment)
Beauty
Blockchain
Publishing
Food and Beverage
Social Network
Web3
Big Data
Video Games
Education
Medical
Wellness
Medical Device
Art
Social Media
Android
Internet
Franchise
Music
Mobile
Legal
Construction
Automotive
Sports
eSports
Hospitality
Cannabis
Mobile Advertising
Biotechnology
FinTech
Consumer
Transportation
Real Estate
Enterprise
Software
Life Science
B2B
Any country
South Korea
Oceania
Asia
Brazil
Africa
Middle East
Europe
LATAM
Saudi Arabia
Singapore
Finland
Gibraltar
Greece
Norway
Israel
Italy
Lebanon
Liberia
Mexico
Tajikistan
Taiwan
Zimbabwe
Puerto Rico
Russian Federation
Nigeria
Sweden
San Marino
Togo
Tunisia
Zambia
Isle of Man
Mongolia
Pakistan
Romania
Oman
Colombia
Cameroon
India
Australia
New Zealand
China
Indonesia
Sri Lanka
Vietnam
Armenia
Austria
Barbados
Albania
Bangladesh
Belgium
Argentina
Bahrain
Costa Rica
Belarus
Belize
Chile
Switzerland
Czech Republic
Estonia
Algeria
Honduras
Iceland
Cambodia
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Slovenia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Japan
Seychelles
Germany
Canada
United Kingdom
Ireland
Cyprus
Qatar
Spain
South Africa
United Arab Emirates
Azerbaijan
Bulgaria
Bolivia
Bermuda
Bahamas
Egypt
France
Georgia
Faroe Islands
Denmark
Dominican Republic
Ecuador
Croatia
Hong Kong
Ghana
Ethiopia
Grenada
Iraq
Hungary
Jordan
Jersey
Liechtenstein
Mali
Myanmar
Latvia
Morocco
Lithuania
Malaysia
Peru
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Thailand
El Salvador
Senegal
Tanzania
Uruguay
Ukraine
United States
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Angel Investors in Europe (June 2026)

The most active angel investors investing in Europe Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
9 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Nadav Rosenberg
Angel
4 United Kingdom, France, Israel Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Software $850k–$19M
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
Jeff Dean
Angel
3 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$53M
Stefano Bernardi
Angel
3 Italy, United Kingdom, France Seed, Pre-Seed Software, Biotechnology, Artificial Intelligence $100k–$45M
Thor Bjorgolfsson
Angel
2 United Kingdom, Germany Seed, Series A, Series C Big Data, TV, B2B $26M–$26M
Michael Novogratz
Angel
2 United States, India, Germany Seed, Series A Blockchain, Cryptocurrency, FinTech $953k–$38M
Annie Vereecken
Angel
2 Belgium Seed, Series A Medical, Biotechnology, Hospital $2M–$27M
Mati Staniszewski
Angel
2 United States, United Kingdom, Poland Seed, Pre-Seed, Series A Artificial Intelligence, Software, SaaS $2M–$40M
Aidan Gomez
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1.8M–$12M
Nicholas Edwards
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
David Helgason
Angel
2 United States, Denmark, Finland Seed, Series A Software, Gaming, Information Technology $1.1M–$30M
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note FinTech, Finance, Life Science
Jan Hruska
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
Sauli Törmälä
Angel
2 Finland Seed Life Science, Biotechnology $584k–$1.3M
Pierre Drion
Angel
2 Belgium Series A, Series B Biotechnology, Health Care, Life Science $8.8M–$26M
Leena Niemistö
Angel
2 Finland, United States Seed, Pre-Seed Health Care, Software, E-Commerce $480k–$3.2M
Mark Evans
Angel
2 United Kingdom, United States, The Netherlands Series A, Seed, Series C Software, E-Commerce, Health Care $1.4M–$24M
Jude Gomila
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$4.7M
Holger Hübner
Angel
2 Germany Seed, Pre-Seed B2B, SaaS, Audio $177k–$987k
Sylvain Zimmer
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Angel Software, SaaS, Food and Beverage $200k–$10M
Ed Parkinson
Angel
2 United Kingdom Seed Software, Health Care, Life Science $1.8M–$3.3M
Damien Lane
Angel
2 United Kingdom, United States, Ireland Seed, Pre-Seed, Series A SaaS, Software, Health Care $459k–$16M
Ian Hogarth
Angel
2 United Kingdom, United States, Germany Seed, Series A, Pre-Seed Software, E-Commerce, Artificial Intelligence $668k–$28M
Darrin Disley
Angel
2 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $458k–$3.7M
Luc Vauterin
Angel
2 Belgium Seed, Series A Life Science, Data Integration, Data Visualization
Albert Wenger
Angel
2 United States, Germany, Switzerland Series A, Series B, Seed Software, Manufacturing, Internet $650k–$38M
Andrew Nutter
Angel
2 France, United Kingdom, United States Seed, Pre-Seed Software, SaaS, FinTech $550k–$4.9M
Nico Wittenborn
Angel
2 United States, Germany, France Seed, Series A, Series B Software, Apps, Wellness $1.6M–$88M
Bradley Horowitz
Angel
2 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $150k–$120M
Josefin Landgård
Angel
1 Sweden, France Seed, Angel, Pre-Seed Health Care, Medical, Women's
Alfons Hidalgo
Angel
1 Spain Medical, Biopharma, Life Science
Jon Oringer
Angel
1 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Health Care
Sebastian Lombardo
Angel
1 France, United States Seed Apps, Internet, Lifestyle
Fiona Pathiraja
Angel
1 United Kingdom, Germany, Armenia Pre-Seed, Seed, Series A Health Care, Biotechnology, Wellness
Bertrand Jacquelot
Angel
1 France, United States Pre-Seed, Seed, Angel E-Commerce, Information Technology, Food and Beverage
Arman Anatürk
Angel
1 Spain, Israel, Germany Seed, Pre-Seed Biotechnology, Food and Beverage, Wellness
Milad Alucozai
Angel
1 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical
Per Falholt
Angel
1 Denmark Seed, Pre-Seed, Series A Biotechnology, Robotics, Life Science
Arturo Elizondo
Angel
1 Spain, Switzerland Seed, Pre-Seed Wellness, Life Science, Biotechnology
Huw Bishop
Angel
1 United Kingdom Angel EdTech, Training, E-Learning
Fidji Simo
Angel
1 United States, United Kingdom, France Seed, Series A, Series B Software, Health Care, Internet
Nadav Ben-Chanoch
Angel
1 United States, United Kingdom, France Seed, Pre-Seed Software, FinTech, Information Technology
Evren Ucok
Angel
1 Turkey, Belgium Series A Medical, Health Care, Life Science
Mark Gillespie
Angel
1 United States, United Kingdom, India Seed, Series B Music, Internet, Video
David Brandes
Angel
1 Spain Seed Wellness, Life Science, Biotechnology
Inaki Berenguer
Angel
1 Spain, United States, United Kingdom Seed, Angel, Pre-Seed Financial Services, FinTech, E-Commerce
Bhavik Bajaj
Angel
1 United States, United Kingdom, Switzerland Pre-Seed, Seed, Angel Information Technology, Software, FinTech
Ryan Bethencourt
Angel
1 United States, Chile, India Pre-Seed, Seed, Angel Biotechnology, Food Processing, Food and Beverage
Edward Lando
Angel
1 United States, United Kingdom, France Seed, Pre-Seed Software, Information Technology, Health Care
Access all 50 angel investors in Europe Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 9 investments in Europe Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 61
  • Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 4 investments in Europe Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Show all investments...

Andrew Keys
Angel · 3 investments in Europe Life Science startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 3 investments in Europe Life Science startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 91
  • Round size: Seed $2.5M–$34M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
  • Belfort — Belfort is specialising in technology that accelerates encrypted data processing, allowing it to be done in real time without ever decrypting the data.
  • depthfirst — An AI-native security platform that understands your code, business logic, and infrastructure to find more vulnerabilities, slash false positives, and give developers actionable fixes in their workflow.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in Europe Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Show all investments...

Thor Bjorgolfsson
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.

Show more...

Investment focus

  • Industry: Big Data, TV, B2B
  • Stage:Seed, Series A, Series C
  • Geography: United Kingdom, Germany

Investor stats

  • Total investments: 6
  • Round size: Series A $26M–$26M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Show all investments...

Michael Novogratz
Angel · New York, New York, United States · 2 investments in Europe Life Science startups

Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, FinTech
  • Stage:Seed, Series A
  • Geography: United States, India, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $953k–$8M; Series A $11M–$38M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • CryptoQuant — CryptoQuant is a community-driven analytics platform to lower hurdles of data-based decisions. Crypto investors often fail to make data-based decisions due to a lack of time and knowledge. We lower the hurdles of data-based decisions by saving research time and decreasing the knowledge gap.
  • Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Show all investments...

Annie Vereecken
Angel · Antwerp, Antwerpen, Belgium · 2 investments in Europe Life Science startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$6M; Series A $8.2M–$27M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Mati Staniszewski
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Mati Staniszewski is the Co-Founder of ElevenLabs.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Poland

Investor stats

  • Total investments: 15
  • Round size: Seed $5M–$17M; Pre-Seed $2M–$5M; Series A $16M–$40M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CodeWords
  • VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
  • Elastics — Elastics is an AI-native operating system for prediction markets and beyond. Powered by auditable AI agents, it allows traders to build and automate trading workflows in plain language, from signal generation to live execution.
Show all investments...

Aidan Gomez
Angel · Oxford, Arkansas, United States · 2 investments in Europe Life Science startups

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 17
  • Round size: Seed $2.4M–$12M; Pre-Seed $1.8M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in Europe Life Science startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 2 investments in Europe Life Science startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Information Technology
  • Stage:Seed, Series A
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 71
  • Round size: Seed $1.1M–$8M; Series A $4.3M–$30M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Yousician — Yousician is a fun way to learn the guitar, piano, bass, ukulele or singing. Enjoy thousands of songs with Yousician as your personal music teacher!
  • Absurd:Joy — absurd:joy is bringing joy to remote collaboration with Tangle
  • Noice — Join the team build an awesome combo of social x playful x platform.
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in Europe Life Science startups

Robert Kopple

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Jan Hruska
Angel · 2 investments in Europe Life Science startups

Jan Hruska

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Sauli Törmälä
Angel · Helsinki, Southern Finland, Finland · 2 investments in Europe Life Science startups

Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Round size: Seed $584k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Europe Life Science startups

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Round size: Series A $8.8M–$14M; Series B $18M–$26M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Leena Niemistö
Angel · Helsinki, Southern Finland, Finland · 2 investments in Europe Life Science startups

Leena Niemistö

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: Finland, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $480k–$3.2M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Mark Evans
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Series A, Seed, Series C
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 35
  • Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$24M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • 8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
  • Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 2 investments in Europe Life Science startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1.4M–$4.7M; Angel $190k–$1.3M; Pre-Seed $1M–$2.8M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
  • Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Show all investments...

Holger Hübner
Angel · Hamburg, Hamburg, Germany · 2 investments in Europe Life Science startups

Holger Hübner

Show more...

Investment focus

  • Industry: B2B, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sylvain Zimmer
Angel · Paris, Ile-de-France, France · 2 investments in Europe Life Science startups

Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.

Show more...

Investment focus

  • Industry: Software, SaaS, Food and Beverage
  • Stage:Seed, Pre-Seed, Angel
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $637k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

Ed Parkinson
Angel · 2 investments in Europe Life Science startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $1.8M–$3.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: SaaS, Software, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 38
  • Round size: Seed $459k–$3.1M; Pre-Seed $605k–$1M; Series A $3.2M–$16M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
  • IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 2 investments in Europe Life Science startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 55
  • Round size: Seed $1.5M–$8.8M; Pre-Seed $668k–$7.7M; Series A $11M–$28M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Blloc — The ultimate smartphone experience. Boost your productivity. Focus on what matters.
  • Cordless — Bridging the gap between voice and text
  • Heygo — Explore places to visit within the UK and around the world on Rest Less. Get inspired and plan trips to holiday destinations with us.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in Europe Life Science startups

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $458k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Luc Vauterin
Angel · 2 investments in Europe Life Science startups

Luc Vauterin - Board Member @ ONTOFORCE

Show more...

Investment focus

  • Industry: Life Science, Data Integration, Data Visualization
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Albert Wenger
Angel · New York, New York, United States · 2 investments in Europe Life Science startups

Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Internet
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 104
  • Round size: Seed $650k–$13M; Series A $1M–$38M; Series B $4.3M–$30M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • DiviGas — DiviGas is an oil and gas company that developed a new process for manufacturing membranes which has yielded vastly superior results to what a membrane can do. The company was founded in 2019 and headquartered in Central Region, Singapore.
  • Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
  • Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in Europe Life Science startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants
  • Jump — Jump takes the hassle out of being a freelancer. We accompany hundreds of freelancers in their daily lives by securing their adventure. Relax, we take care of everything.
  • Core Biogenesis — Biodesigning the Future of Regenerative Medicine & Skincare
Show all investments...

Nico Wittenborn
Angel · New York, New York, United States · 2 investments in Europe Life Science startups

Nico Wittenborn is an Investor at Adjacent.

Show more...

Investment focus

  • Industry: Software, Apps, Wellness
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, France

Investor stats

  • Total investments: 42
  • Round size: Seed $1.6M–$8.5M; Series A $7.1M–$30M; Series B $7.5M–$88M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Niantic — Niantic’s mission is to use emerging technology to enrich our experiences as human beings in the physical world. We seek to build products that inspire movement, exploration, and face-to-face social interaction. Originally formed at Google in 2010, we are now an independent company with a strong group of investors including Nintendo, The PokémonCompany, and Alsop Louie Partners. We’re focused on building games that get people outside and exploring by enabling our players to have fun while visiting new places, learning about the world around them, and meeting new friends. We’ve launched Ingress, an immersive real-world mobile game played by millions of people; it's been downloaded more than 20 million times and is played in over 200 countries and territories worldwide. We've also developed Pokémon GO, which has broken records around the world and has been downloaded more than 750 million times in its first year.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Sunnyside — Sunnyside is the #1 alcohol moderation app helping 600,000+ people drink less through tracking, coaching, and optional naltrexone via telehealth. Start your free 15-day trial.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 2 investments in Europe Life Science startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 114
  • Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
  • Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Josefin Landgård
Angel · Stockholm, Stockholms Lan, Sweden · 1 investments in Europe Life Science startups

Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.

Show more...

Investment focus

  • Industry: Health Care, Medical, Women's
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Sweden, France

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Estmn — Estrid is an online portal that offers women's personal care products.
  • Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
  • Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Show all investments...

Alfons Hidalgo
Angel · 1 investments in Europe Life Science startups

Alfons Hidalgo

Show more...

Investment focus

  • Industry: Medical, Biopharma, Life Science
  • Geography: Spain

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Show all investments...

Jon Oringer
Angel · New York, New York, United States · 1 investments in Europe Life Science startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 114
  • Lead/follow: no public data

Portfolio highlights

  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
  • Zamp — We take care of sales tax, so you don't have to.
  • NewHomesMate — Find, compare and buy a new construction home - all in one place.
Show all investments...

Sebastian Lombardo
Angel · 1 investments in Europe Life Science startups

Sebastian Lombardo - CEO @ Valtech

Show more...

Investment focus

  • Industry: Apps, Internet, Lifestyle
  • Stage:Seed
  • Geography: France, United States

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
  • Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Show all investments...

Fiona Pathiraja
Angel · 1 investments in Europe Life Science startups

Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Wellness
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, Germany, Armenia

Investor stats

  • Total investments: 15
  • Lead/follow: no public data

Portfolio highlights

  • Unfabled — Menstrual care and wellness products for your cycle. Organic period products in sustainable packaging. Curated brands for skincare, sleep, cravings, cramping, mood swings, and relaxation. For all your self-care needs, we have you covered.
  • Bloom Money — Bloom Money is a savings club app designed to help growing communities in migrant communities and use technology to promote community, safety, and convenience.
  • Everyman Health — Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert.
Show all investments...

Bertrand Jacquelot
Angel · Paris, Ile-de-France, France · 1 investments in Europe Life Science startups

Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.

Show more...

Investment focus

  • Industry: E-Commerce, Information Technology, Food and Beverage
  • Stage:Pre-Seed, Seed, Angel
  • Geography: France, United States

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Show all investments...

Arman Anatürk
Angel · Lausanne, Vaud, Switzerland · 1 investments in Europe Life Science startups

Arman Anatürk is Co-Founder @ FoodHack.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Wellness
  • Stage:Seed, Pre-Seed
  • Geography: Spain, Israel, Germany

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 1 investments in Europe Life Science startups

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 47
  • Lead/follow: no public data

Portfolio highlights

  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Show all investments...

Per Falholt
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in Europe Life Science startups

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Arturo Elizondo
Angel · San Francisco, California, United States · 1 investments in Europe Life Science startups

Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.

Show more...

Investment focus

  • Industry: Wellness, Life Science, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Spain, Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Huw Bishop
Angel · 1 investments in Europe Life Science startups

Huw Bishop is an individual investor.

Show more...

Investment focus

  • Industry: EdTech, Training, E-Learning
  • Stage:Angel
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • clear_pixel VR — Build real-world laboratory skills in virtual reality. Our VR simulations teach micropipetting, mouse injections, and molecular neuroscience. Scalable, ethical, and cost-effective.
Show all investments...

Fidji Simo
Angel · Palo Alto, California, United States · 1 investments in Europe Life Science startups

Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.

Show more...

Investment focus

  • Industry: Software, Health Care, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Somite — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
  • Owner — Owner gives you the same tools that major national brands use to drive sales. Online ordering proven to grow sales. Mobile app with rewards. And more.
  • Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 1 investments in Europe Life Science startups

Nadav Ben-Chanoch - Partner @ Pareto Holdings

Show more...

Investment focus

  • Industry: Software, FinTech, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 111
  • Lead/follow: no public data

Portfolio highlights

  • Swaap — We we build & operate onchain trading systems.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
Show all investments...

Evren Ucok
Angel · Istanbul, Istanbul, Turkey · 1 investments in Europe Life Science startups

Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Turkey, Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Mark Gillespie
Angel · Los Angeles, California, United States · 1 investments in Europe Life Science startups

Recently named as one of Billboard’s 2021 Change Agents, as well as one of the World's Greatest Managers by Music Business Worldwide, Mark Gillespie is a world-class British CEO, manager, and producer whose vision and drive have led him to build Three Six Zero into the global entertainment powerhouse that it is today. Widely recognized as oneof the industry's preeminent executives, Gillespie has been instrumental in guiding the careers of Frank Ocean and Calvin Harris, most recently closing a deal in excess of $100MM for his publishing catalogue. With offices in Los Angeles, Miami, and London, Gillespie provides the leadership necessary to ensure that Three Six Zero and its clients remain at the forefront of the music, film, television, and digital content landscapeFueled by a lifelong passion for music, Gillespie launched his career in his hometown of Birmingham, UK, where he proved to be an invaluable asset for superclub Godskitchen. Since then, he has established himself as a visionary in the entertainment industry, having worked in partnerships with Sony Music Entertainment, Jay-Z and Roc Nation, and most recently Westbrook Entertainment, whose talent roster includes Will Smith, Jada Pinkett Smith, and the entire Smith Family.A relentless pioneer and entrepreneur, Gillespie has joined forces with Pete Tong MBE to run Three Six Zero Recordings, his own in-house record label, while continuing to expand an already successful presence in film and television. Along with several other projects in the pipeline, the company's first feature film – prestige drama, VOX LUX – starring Natalie Portman and Jude Law, including an original soundtrack by Sia, was released in 2018.With a passion for innovation at the intersection of media, technology, and apparel, Gillespie has invested in companies such as Outdoor Voices, Stance, Ember Technologies, Stem Disintermedia, and Saavn. Committed to giving back and continuously fostering artistic talent, Gillespie has also remained a longtime philanthropist and advocate, sitting on both the Music Committee of Children in Conflict and the core screening panel of the Recording Academy. In his downtime, Gillespie enjoys following Manchester United and is an avid collector of modern art.

Show more...

Investment focus

  • Industry: Music, Internet, Video
  • Stage:Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 20
  • Lead/follow: no public data

Portfolio highlights

  • Bkstg — Bkstg was founded by tech and music entrepreneurs to reinvent the way artists and fans connect by creating a new form of direct relationship that’s never existed before.
  • Hyperice — HyperIce is a recovery and movement enhancement technology company specializing in vibration, percussion, and thermal technology. Its technology is used by the athletes in professional and collegiate training rooms and fitness facilities globally.The company is driven by a mission to provide everyone with the innovative technology in acceleratingrecovery time, preventing injury, and enhancing the body’s ability to move efficiently. HyperIce was founded in 2010 by Anthony Katz.
  • Biosceptre — A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from
Show all investments...

David Brandes
Angel · Berlin, Berlin, Germany · 1 investments in Europe Life Science startups

David Brandes - Managing Director & Co-Founder @ Peace of Meat

Show more...

Investment focus

  • Industry: Wellness, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Spain

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Show all investments...

Inaki Berenguer
Angel · New York, New York, United States · 1 investments in Europe Life Science startups

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, E-Commerce
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 25
  • Lead/follow: no public data

Portfolio highlights

  • Ukio — Artfully designed fully furnished apartments available for extended stays
  • Paack — Find the ideal delivery solution to integrate into your e-commerce. We adapt to your business, providing your customers with an amazing experience.
  • Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Show all investments...

Bhavik Bajaj
Angel · 1 investments in Europe Life Science startups

Bhavik Bajaj

Show more...

Investment focus

  • Industry: Information Technology, Software, FinTech
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 74
  • Lead/follow: no public data

Portfolio highlights

  • Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
  • ORA Technologies — E-Commerce, Super App
  • THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING
Show all investments...

Ryan Bethencourt
Angel · San Francisco, California, United States · 1 investments in Europe Life Science startups

Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.

Show more...

Investment focus

  • Industry: Biotechnology, Food Processing, Food and Beverage
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, Chile, India

Investor stats

  • Total investments: 14
  • Lead/follow: no public data

Portfolio highlights

  • WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
  • Sobo Foods — Sobo Foods is a plant based comfort food provider.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 1 investments in Europe Life Science startups

Edward Lando is the Founder of Pareto Holdings. He previously worked at Horizons School of Technology as a Co-Founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 246
  • Lead/follow: no public data

Portfolio highlights

  • SiPay — Sipay is a next-generation financial technology company offering a comprehensive all-in-one financial services platform. It enables B2B, B2C, and Sipay as a Service (Embedded Finance) customers to address all their banking and financial needs without requiring any other partners.
  • Syntetica — Syntetica is a nylon recycling startup that addresses pollution in the fashion industry by transforming discarded nylon products into high-quality, reusable materials. Their innovative processes help reduce waste, conserve resources, and promote sustainability within the fashion sector.
  • Unicorn Auctions — Unicorn Auctions offers rare spirits auctions to buyers, sellers, and collectors. They provide ios and android apps in addition to their web bidding platform for digital auctions. To ensure examination of every asset listed, they must take physical possession of their items.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in Europe Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists